Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics
10/7 12:41
Altimmune (NASDAQ: ALT) and Viking Therapeutics (NASDAQ: VKTX) are a pair of biotechs planning to follow in the footsteps of Novo Nordisk and Eli Lilly and develop GLP-1-targeted medicines for obesity like Wegovy and Zepbound. Both companies have a plausible pathway to continue m...